What is she best known for?
The fields of study she is best known for:
- Neuroscience
- Dopamine
- Neurotransmitter
Marianne Amalric mostly deals with Neuroscience, Basal ganglia, Dopamine, Pharmacology and Subthalamic nucleus.
Her research integrates issues of Hypothalamus, Addiction and Thalamus in her study of Basal ganglia.
Striatum and Dopaminergic are subfields of Dopamine in which her conducts study.
Her Striatum research focuses on subjects like Nucleus accumbens, which are linked to Amygdala, Forebrain, Nigrostriatal pathway and Caudate nucleus.
Her work in Pharmacology addresses subjects such as Metabotropic glutamate receptor, which are connected to disciplines such as Metabotropic receptor.
Marianne Amalric combines subjects such as Food intake, Ibotenic acid and MPTP with her study of Subthalamic nucleus.
Her most cited work include:
- The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. (249 citations)
- In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit (207 citations)
- Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats (186 citations)
What are the main themes of her work throughout her whole career to date?
Neuroscience, Dopamine, Basal ganglia, Pharmacology and Metabotropic glutamate receptor are her primary areas of study.
The study incorporates disciplines such as Parkinson's disease and Subthalamic nucleus in addition to Neuroscience.
Her work deals with themes such as Cholinergic and Neurotransmitter, which intersect with Dopamine.
The various areas that Marianne Amalric examines in her Basal ganglia study include Caudate nucleus, Glutamatergic, Parkinsonism and Motor control.
Her Pharmacology study combines topics in areas such as Metabotropic glutamate receptor 1, Metabotropic glutamate receptor 4, Agonist, Receptor and Metabotropic glutamate receptor 8.
Her Metabotropic glutamate receptor research is multidisciplinary, incorporating elements of Receptor antagonist and Metabotropic receptor.
She most often published in these fields:
- Neuroscience (68.70%)
- Dopamine (34.78%)
- Basal ganglia (28.70%)
What were the highlights of her more recent work (between 2011-2021)?
- Neuroscience (68.70%)
- Dopamine (34.78%)
- Basal ganglia (28.70%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Neuroscience, Dopamine, Basal ganglia, Substantia nigra and Striatum.
The Neuroscience study combines topics in areas such as Parkinson's disease, Metabotropic glutamate receptor and Subthalamic nucleus.
Her Metabotropic glutamate receptor study integrates concerns from other disciplines, such as Pharmacology and Metabotropic receptor.
Her research in Dopamine tackles topics such as Cholinergic which are related to areas like Optogenetics.
Marianne Amalric focuses mostly in the field of Substantia nigra, narrowing it down to topics relating to Apamin and, in certain cases, Oxidopamine.
Her studies examine the connections between Striatum and genetics, as well as such issues in Cholinergic neuron, with regards to Tyrosine hydroxylase, Nucleus accumbens, Ventral striatum and Direct pathway of movement.
Between 2011 and 2021, her most popular works were:
- The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease (79 citations)
- A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential (72 citations)
- Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism (70 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Neuroscience
- Neurotransmitter
Her primary areas of study are Pharmacology, Neuroscience, Metabotropic glutamate receptor 4, Basal ganglia and Dopamine.
Her Pharmacology study incorporates themes from Allosteric modulator, Metabotropic glutamate receptor and Receptor antagonist.
Her work investigates the relationship between Metabotropic glutamate receptor and topics such as Metabotropic receptor that intersect with problems in Glutamatergic.
Her Metabotropic glutamate receptor 4 research includes themes of Substantia nigra, Metabotropic glutamate receptor 1, Catalepsy and Antagonist.
Her Metabotropic glutamate receptor 1 research is multidisciplinary, relying on both Metabotropic glutamate receptor 5, Metabotropic glutamate receptor 3, Metabotropic glutamate receptor 2, Metabotropic glutamate receptor 7 and Metabotropic glutamate receptor 8.
In her work, Parkinsonism, Anatomy, Neural correlates of consciousness and Striatum is strongly intertwined with Cholinergic, which is a subfield of Basal ganglia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
